The Prognostic Impact of Comorbidities on Renal Cancer, 1995 to 2006: A Danish Population Based Study

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 35-40

  Lund, Lars ^a,c   Jacobsen, Jacob ^b   Nørgaard, Mette ^b   McLaughlin, Joseph K ^c,d   Blot, William J ^c,d   Borre, Michael ^b   Sørensen, Henrik T ^b,c,e  

^a VIBORG HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^e BOSTON UNIVERSITY   (United States)

Author keywords

comorbidity; Denmark; kidney; kidney neoplasms; mortality

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; DENMARK; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 67349273961     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.136     Document Type: Article

References (22)

1. Cancer Incidence in Denmark (2000), National Board of Health Copenhagen, Copenhagen 204
2. Parkin D.M., Muir C.S., Whelan S.L., Gao Y.T., Ferlay J., and Powell J. Cancer incidence in five countries. IARC Sci 120 (1992) 978
3. Chow W.H., Devesa S.S., Warren J.L., and Fraumeni Jr. J.F. Rising incidence of renal cell cancer in the United States. JAMA 281 (1999) 1628
4. Konnak J., and Grossman H. Renal cell carcinoma as an incidental finding. J Urol 134 (1985) 1094
5. McLaughlin J.K., Lindblad P., Mellemgaard A., McCredie M., Mandel J.S., Schlehofer B., et al. International renal-cell cancer study. I. Tobacco use. Int J Cancer 60 (1995) 194
6. Mellemgaard A., Lindblad P., Schlehofer B., Bergström R., Mandel J.S., McCredie M., et al. International renal-cell cancer study. III. Role of weight, height, physical activity, and the use of amphetamines. Int J Cancer 60 (1995) 350
7. McLaughlin J.K., Chow W.H., Mandel J.S., Mellemgaard A., McCredie M., Lindblad P., et al. International renal-cell cancer study. VII. Role of diuretics, other antihypertensive medications and hypertension. Int J Cancer 60 (1995) 216
8. de Groot V., Beckerman H., Lankhorst G.J., and Bouter L.M. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 56 (2003) 221
9. Gettman M., Boelter C.W., Cheville J.C., Zincke H., Bryant S.C., and Blute M.L. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 169 (2003) 1282
10. Santos Arrontes D., FernándezAceñero M.J., GarcíaGonzález J.I., MartínMuñoz M., and PaniaguaAndrés P. Survival analysis of clear cell renal carcinoma according to the Charlson comorbidity index. J Urol 179 (2008) 857
11. Berger D.A., Megwalu I.I., Vlahiotis A., Radwan M.H., Serrano M.F., Humphrey P.A., et al. Impact of comorbidity on overall survival in patients surgically treated for renal cell carcinoma. Urology 72 (2008) 359
12. Andersen T.F., Madsen M., Jorgensen J., Mellemkjoer L., and Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999) 263
13. Tetsche M.S., Nørgaard M., Skriver M.V., Andersen E.S., Lash T.L., and Sørensen H.T. Accuracy of ovarian cancer ICD-10 diagnosis in a Danish population-based Hospital discharge registry. Eur J Gyn Oncol 26 (2005) 266
14. Frank L. Epidemiology. When an entire country is a cohort. Science 287 (2000) 2398
15. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373
16. Rothman K.J. Epidemiology: An Introduction. 2nd ed. (2002), Oxford University Press, Oxford
17. Gaist D., Sørensen H.T., and Hallas J. The Danish prescription registries. Dan Med Bull 44 (1997) 445
18. Sorensen H.T. Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Safety Med 10 (1997) 1
19. Bo M., Cacello E., Ghiggia F., Corsinovi L., and Bosco F. Predictive factors of clinical outcome in older surgical patients. Arch Gerontol Geriatr 44 (2006) 215
20. Corman J.M., Penson D.F., Hur K., Khuri S.F., Daley J., Henderson W., et al. Comparison of complications after radical and partial nephrectomy: results from the national Veterans Administration surgical quality improvement program. BJU Int 86 (2000) 782
21. Dunn M.D., Portes A.J., and Shalhav A.L. Laparoscopic versus open nephrectomy: a 9-year experience. J Urol 164 (2000) 1153
22. Naya Y., Tobe T., Suyama T., Araki K., Komiya A., Suzuki H., et al. The efficacy and safety of laparoscopic nephrectomy in patients with three or more comorbidities. Int J Urol 14 (2007) 17